Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer
Clinical trial NCT02200757 · COMPLETED
Trial details
- NCT number
- NCT02200757
- Sponsor
- ImmunityBio, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-20
- Primary completion
- 2017-05-15
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.